Targeting the Ezrin Adaptor Protein Sensitizes Metastatic Breast Cancer Cells to Chemotherapy and Reduces Neoadjuvant Therapy–induced Metastasis

Victoria Hoskin(Ontario Institute for Cancer Research), Peter A. Greer(Queen's University)
Cancer Research Communications
May 25, 2022
Cited by 11


Related Papers